Trial Profile
Phase I trial of low-dose ITI 007 in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Lumateperone (Primary)
- Indications Insomnia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Intra-Cellular Therapies
- 29 Jun 2007 New trial record.